Edurant

Edurant (Rilpivirine) is an antiretroviral medication used to manage HIV-1 infection. This oral tablet is part of combination therapy to control the virus and improve immune function.

Edurant is primarily used in combination with other antiretroviral drugs to treat HIV-1 infection. It works by inhibiting the virus's ability to replicate, helping to reduce viral load and maintain immune system health. This medication is not a cure for HIV but helps manage the condition when used as directed by a healthcare provider.

Common effects of Edurant may include headache, dizziness, nausea, and rash. Some individuals might experience changes in body fat distribution or mood. These effects vary and are not experienced by everyone taking the medication.

Edurant should be handled with care, stored properly, and taken as prescribed. It is important to follow medical advice regarding diet, other medications, and lifestyle factors that might affect its efficacy. Regular monitoring and communication with a healthcare provider are recommended.

Edurant may interact with certain medications, including antacids, proton pump inhibitors, and other drugs that affect liver enzymes. Alcohol and other substances might also influence its effects. Always consult a healthcare provider before combining Edurant with other treatments.